John B. Landis - Net Worth and Insider Trading
John B. Landis Net Worth
The estimated net worth of John B. Landis is at least $135,040 dollars as of 2024-11-13. John B. Landis is the Director of Inotiv Inc and owns about 30,000 shares of Inotiv Inc (NOTV) stock worth over $90,600. John B. Landis is also the Director of EyePoint Pharmaceuticals Inc and owns about 4,000 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $44,440. Details can be seen in John B. Landis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John B. Landis has not made any transactions after 2019-05-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John B. Landis
John B. Landis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John B. Landis owns 2 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , and Inotiv Inc (NOTV) .
Click here to see the complete history of John B. Landis’s form 4 insider trades.
Insider Ownership Summary of John B. Landis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EYPT | EyePoint Pharmaceuticals Inc | 2019-05-13 | director |
| NOTV | Inotiv Inc | 2012-08-17 | director |
John B. Landis Latest Holdings Summary
John B. Landis currently owns a total of 2 stocks. Among these stocks, John B. Landis owns 30,000 shares of Inotiv Inc (NOTV) as of August 17, 2012, with a value of $90,600 and a weighting of 67.09%. John B. Landis also owns 4,000 shares of EyePoint Pharmaceuticals Inc (EYPT) as of May 13, 2019, with a value of $44,440 and a weighting of 32.91%.
Latest Holdings of John B. Landis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NOTV | Inotiv Inc | 2012-08-17 | 30,000 | 3.02 | 90,600 |
| EYPT | EyePoint Pharmaceuticals Inc | 2019-05-13 | 4,000 | 11.11 | 44,440 |
Holding Weightings of John B. Landis
John B. Landis Form 4 Trading Tracker
According to the SEC Form 4 filings, John B. Landis has made a total of 0 transactions in Inotiv Inc (NOTV) over the past 5 years. The most-recent trade in Inotiv Inc is the acquisition of 30,000 shares on August 17, 2012, which cost John B. Landis around $37,800.
According to the SEC Form 4 filings, John B. Landis has made a total of 0 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 4,000 shares on May 13, 2019, which cost John B. Landis around $69,600.
Insider Trading History of John B. Landis
- 1
John B. Landis Trading Performance
GuruFocus tracks the stock performance after each of John B. Landis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John B. Landis is -6.17%. GuruFocus also compares John B. Landis's trading performance to market benchmark return within the same time period. The performance of stocks bought by John B. Landis within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John B. Landis's insider trading performs compared to the benchmark.
Performance of John B. Landis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.13 | | | | | |
| Relative Return to S&P 500(%) | 3.19 | | | | | |
John B. Landis Ownership Network
Ownership Network List of John B. Landis
Ownership Network Relation of John B. Landis
John B. Landis Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
John B. Landis is the director of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include director & President and CEO Nancy Lurker , SVP & Chief Commercial Officer David Scott Jones , and Chief Medical Officer Dario A. Paggiarino .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, John B. Landis made no insider transaction in EyePoint Pharmaceuticals Inc (EYPT). Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 23,240 shares, with a net purchase of 23,240 shares. During the past 18 months, 4,229,811 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,486 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
John B. Landis Mailing Address
Above is the net worth, insider trading, and ownership report for John B. Landis. You might contact John B. Landis via mailing address: 1700 Kent Avenue, West Lafayette In 46906.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
